MCI Oncology Academic Educational Series: Emergent Complications of Cancer Therapy: Hypersensitivity/Infusion Reactions and the Impact of Febrile Neutropenia

Miami, FL US
September 24, 2018

The use of anthracycline-based combination chemotherapy to treat diffuse aggressive non-Hodgkin lymphoma (NHL) in older patients is complicated by the frequent occurrence of neutropenia, febrile neutropenia (FN), and serious infections.  

During this lecture Ms. Sinclair and Ms. Alonso will discuss early recognition of hypersensitivity reaction along with immediate and post-care for infusion reaction.

Target Audience

Oncology Nurses, Oncologists, Radiation Oncologists, Hematology Oncologists, Radiation Therapists, Pharmacists, Patient Navigators and other interested healthcare providers.

Learning Objectives

  • Discuss early recognition, immediate and post-care for infusion reactions, cytokine release syndrome, and anaphylaxis.
  • Define severe and febrile neutropenia in cancer patients, discuss relationship between ANC and risk of infection and discuss short and long-term mortality associated with febrile neutropenia.
Course summary
Available credit: 
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Florida Board of Nursing
  • 1.50 Nurse Practitioners
  • 1.50 Florida Board of Occupational Therapy
  • 1.50 Florida Board of Pharmacy
  • 1.50 General certificate of attendance
Course opens: 
08/01/2018
Course expires: 
10/26/2018
Event starts: 
09/24/2018 - 7:00pm
Event ends: 
09/24/2018 - 8:30pm
Rating: 
0
Miami Cancer Institute
8900 N. Kendall Dr
Tumor Board Conference Room: MCI 3N110
Miami, FL 33176
United States
+1 (305) 671-2690
 

Miri M. Sinclair, ARNP
Miami Cancer Institute

Miri M. Sinclair, ARNP indicated that neither she nor her spouse/partner has relevant financial relationships with commercial interest companies, and she will not include off-label or unapproved product usage in her presentation(s) or discussion(s).

Dayne Alonso, P.A.

Dayne Alonso, P.A. indicated that neither she nor her spouse/partner has relevant financial relationships with commercial interest companies, and she will not include off-label or unapproved product usage in her presentation(s) or discussion(s).

Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose.

Disclosure Policy and Disclaimer

Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.

Baptist Health South Florida designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity has been approved for 1.5 credit hours, CE Broker Course #20-665784, by the Florida Boards of Medicine, Osteopathic Medicine and the Florida Council of Physician Assistants.

This activity has also been approved for 1.5 credits for Nurse Practitioners, Nurses and Pharmacists. Baptist Health South Florida CE Broker Provider #50-182.

Available Credit

  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Florida Board of Nursing
  • 1.50 Nurse Practitioners
  • 1.50 Florida Board of Occupational Therapy
  • 1.50 Florida Board of Pharmacy
  • 1.50 General certificate of attendance

Accreditation Period

Course opens: 
08/01/2018
Course expires: 
10/26/2018
Please login or register to take this course.

Required Hardware/software

Technical Support: If you are experiencing technical difficulties or have received an error message, please send an email to CME@BaptistHealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.

Technical Support